Zoetis Introduces New AUREOMIX® S Without Penicillin

Product update reinforces commitment to responsible use of antibiotics medically important to human health

FLORHAM PARK, N.J., May 28, 2015 — Zoetis announces the availability of AUREOMIX® S — a medicated feed additive that combines the proven safety and therapeutic strength of chlortetracycline and sulfamethazine without the use of penicillin. AUREOMIX S replaces AUREO S-P 250® and AUREOMIX® Granular 500, the chlortetracycline/sulfamethazine/penicillin combinations that Zoetis voluntarily withdrew last year.

“We worked voluntarily with the Food and Drug Administration [FDA] to remove penicillin from these combinations as a confirmation of our commitment to the responsible use of antibiotics,” said Shelley Stanford, DVM, MS, MBA, Director, U.S. Pork Technical Services, Zoetis. “We all can help maintain the effectiveness of these important resources through practicing responsible use.”

AUREOMIX S is indicated for treatment of bacterial swine enteritis and cervical abscesses during times of stress. The granular formula offers several benefits such as excellent flowability, improved medication distribution in the feed, less dust and stability under high temperatures. AUREOMIX S is available in two formulations:

• Type A: AUREOMIX S 40/40
• Type B: AUREOMIX S 10/10

Along with a portfolio of antimicrobial products, Zoetis also offers a full line of vaccines that help prevent disease and is committed to educating producers on proper and responsible uses of these tools. Training programs, such as Individual Pig Care, provide guidelines so pig caregivers can identify sick animals sooner to help ensure they are treated with the right product at the right time.

Zoetis supports the FDA’s Guidance for Industry 209 and 213 to phase out the use of all medically important antibiotic products labeled for growth promotion and is committed to helping veterinarians, pork producers and the livestock feed industry stay informed in a changing regulatory environment. To learn more about the Zoetis commitment to responsible use of antibiotics, talk to your local representative or visit ResponsibleAntibioticUse.com.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetisUS.com.

For Further Information, Contact:

Christina Lood

Cheryl O’Brien           
Bader Rutter



Mon–Fri, 8:30am–6:30pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.